Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
editas medicine
gene editing
life sciences
national blog main
san francisco blog main
2
×
abbvie
agios therapeutics
allergan
alzheimer's disease
base editing
branden moriarty
broad institute
cas13
clinical trials
crispr
crispr therapeutics
crispr-cas9
cynthia collins
david liu
deals
dna
editor
editr
enzyme
feng zhang
harvard university
intellia therapeutics
john evans
keith joung
leber congenital amaurosis type 10
massachusetts general hospital
michelle robertson
national top stories
nicole gaudelli
parkinson's disease
precise
What
editas
2
×
editing
gene
abbvie
alliance
beam
biotech
cas
crispr
editor
exits
experimental
founders
genetic
gotten
harvard
jump
mass
medicine
medicines
pact
partnership
precise
pruning
research
returning
rights
scientists
spotlights
startup
terminated
therapeutics
treatment
university
version
Language
unset
Current search:
editas
×
boston
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M